Early clinical trials show that Sinovac’s COVID-19 vaccine candidate safely induces an immune response in healthy volunteers within a month of vaccination.
reSET is a 12-week prescription treatment for substance use disorder.
Singapore's Health Sciences Authority has granted conditional approval of remdesivir as a treatment for patients with severe COVID-19.
Lucence has developed a kit that can stabilize COVID-19 test samples and is making 10,000 of the kits freely available to the scientific community.
Nucleic acid drugs have the potential to treat neuromuscular and metabolic diseases where small molecule drugs have failed.
Enleofen Bio will receive more than US$1 billion in earnout payments from Boehringer Ingelheim’s acquisition of worldwide exclusive rights to its preclinical interleukin-11 platform.
With the creation of two new research centres and a billion-dollar fund in China, AstraZeneca looks set to make waves in biomedical research and healthcare in Asia.